期刊名称:VALUE IN HEALTH
期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal

Value in Health is a multidisciplinary peer-reviewed journal reporting on evaluations of medical technologies including pharmaceuticals, biologics, devices, procedures, and other health care interventions. It provides a scientific forum for communicating health economics and outcomes research methods and findings, furthering ISPOR's vision that "society allocate scarce health care resources wisely, fairly, and efficiently." It is also a sounding board for the discussion of health policy issues related to health economics and outcomes studies associated with all medical technologies.
Instructions to Authors
Value in Health is a peer-reviewed publication of the International Society for Pharmacoeconomics and Outcomes Research. Its mission is to provide a forum for the advancement and dissemination of knowledge and research in pharmacoeconomics and the health-related outcomes of disease and treatment processes. The journal therefore solicits original contributions in applied and theoretical pharmacoeconomics, and in the theory, measurement, and analysis of the health-related outcomes relevant to forwarding scholarly and public dialogue about the assessment of value in health and health care. In keeping with its broad mission, Value in Health will also accept methodology papers and critical reviews of empirical and theoretical literature in pharmacoeconomics and outcomes research.
VH does not consider papers reporting data series or data sets that do not include appropriate statistical confidence intervals and/or other measures of statistical imprecision. VH also does not consider papers reporting modeling results that do not include sensitivity analysis of key and influential model parameters.
Authors for whom English is a second language may choose to have their manuscript professionally edited before submission or during the review process. Authors wishing to pursue a professional English-language editing service should make contact and arrange payment with the editing service of their choice. For more details regarding the recommended services, please refer to http://www.blackwellpublishing.com/bauthor/english_language.asp
Manuscript Submission and Specifications Authors should submit manuscripts electronically as email attachments wherever possible. Processing of a manuscript for peer review will begin only once a signed Copyright Transfer, Disclosure, and Acknowledgment form has been received for each author on the manuscript. (This form is available on the Value in Health page of the ISPOR Web site at www.ispor.org. A faxed copy of this completed and signed form is acceptable; fax to 323-843-9900.)
If submissions sent by email are larger than 500 KB, they should be compressed using PKZIP or WINZIP. Regular mail or courier mail submissions should only be made when email submissions are not possible, and should include the document in electronic form on disk.
Authors will be required to assign copyright in their papers. Copyright assignment is a condition of publication and papers will not be passed to the publisher for production unless copyright has been assigned. An appropriate copyright assignment form can be found at the following address: VHE Copyright Assignment Form.
All submissions should be addressed to: Value in Health ISPOR, 3100 Princeton Pike, Suite 3E, Lawrenceville, NJ 08648 . Email: viheditor@ispor.org; fax 323-843-9900.
Cover Letter The cover letter should include: 1) title of the manuscript; 2) name of the document file(s) containing the manuscript and the software (and version) used; 3) name and all contact information for the corresponding author and a statement as to whether the data, models, or methodology used in the research are proprietary; 4) names of all sponsors of the research and a statement of all direct or indirect financial relationships the authors have with the sponsors; and 5) if applicable, a statement that the publication of study results was not contingent on the sponsor's approval or censorship of the manuscript.
Manuscripts Manuscripts must be written in English, typed in either Microsoft Word (Version 5.0 or later) or WordPerfect (version 5.1 or later). Manuscripts should be in 8.5x11-inch page format, double-spaced with 1-inch margins on all sides and size 10 font (Arial or Times New Roman fonts are preferred). Minimal formatting should be used, i.e., no justification, italics, bold, indenting, etc. There should be no hard returns at the end of lines. Double-spacing after each element is requested (e.g., headings, titles, paragraphs, legends). There is no limit on manuscript length, but length in terms of clarity and conciseness will be considered in the editorial process. The "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" should be consulted for specific style issues not addressed here (www.acponline.org, Ann Intern Med 1997;126:36-47).
Title Page The title page should contain the following: 1) title; 2) full names (first and surname) of all authors including academic degrees and afffiliation(s); 3) name, mailing and email addresses, telephone and fax numbers of corresponding author (with whom all correspondence will take place unless other arrangements are made); 4) all sources of financial or other support for the manuscript (if no funding was received, this should be noted on the title page); 5) at least four key words for indexing purposes; and 6) a running title of not more than 45 characters including spaces.
Abstract An abstract of 250 words or less is required, summarizing the work reported in the manuscript. Original research manuscripts should use a structured format for the abstract, i.e., Objectives, Methods, Results, Conclusions.
Text The body of the manuscript should be divided into sections that facilitate reading and comprehension of the material. This should normally include sections with the major headings: Introduction, Methods, Results, Conclusions, Acknowledgments (if needed), References, Figure Legends, Figures, and Tables. There should be no footnotes. References must be numbered with Arabic numerals in square brackets in the text (not superscript), and listed in the reference section in the order in which they are cited. Tables and figures must be cited in the text, and numbered in Arabic numerals in the order in which they are cited. Equations should be presented on separate lines and cited by Arabic numeral in parentheses at the left-hand margin.
Tables and Figures Tables and figures should be clearly labelled and easy to understand without reference to the text. Tables should be double-spaced and each should be presented on a separate page. Statistical estimates should indicate parameter estimates and, as appropriate, t ratios or standard error, statistical significance, sample size, and other relevant information. All abbreviations must be explained below each table. Each table should be numbered and have a self-explanatory title. All illustrations should be reducible by 50-66% of original size without loss of legibility. There will be a charge to the author for printing color illustrations. Each figure must have a corresponding legend, typed double-spaced on a separate page. Each figure must be numbered with an Arabic numeral, and all symbols, arrows, and abbreviations must be explained in the legend. Previously published figures must be accompanied by written authorization for their use and the original source must be named in the legend. For information about digitally submitted graphics, please contact the editorial office (viheditor@ispor.org).
We are happy to receive your artwork in digital format. Please save line artwork (vector graphics) as Encapsulated PostScipt (EPS) and bitmat files (halftones or photographic images) as Tagged Image Format (TIFF), with a resolution of at least 300 dpi at final size. Do not send native file formats. More detailed information can be found on the submission of electronic artwork at http://www.blackwell-science.com/elecmed/digill.htm.
References References should be listed in a separate section and numbered consecutively with Arabic numerals in the order in which they are cited in the text. Citing unpublished or non-peer-reviewed work such as abstracts and presented papers is discouraged. Personal communications may be indicated in the text as long as written acknowledgment from the authors of the communications accompanies the manuscript. Reference style should follow that of Index Medicus. Spell out single-word journals and abbreviate all others according to the style of Index Medicus. If there are more than four authors, use only the names of the first three, followed by et al. The three most common types of references are illustrated below for example.
Journal article: Surname and initials of author(s), title of article, name of journal, year, volume number, first and last page. Arocho R, McMillan CA. Discriminant and criterion evaluation of the U.S.-Spanish version of the SF-36 Health Survey in a Cuban-American population with benign hyperplasia. Med Care 1998;36:766-72.
Book: Surname and initials of author(s)/editor(s), title and subtitle, volume, edition (other than first), city, publisher, year. Johnston J. Econometric Methods (3rd ed.). New York: McGraw-Hill, 1984.
Chapter in Book: Surname and initials of author(s), title of chapter, author(s)/editor(s) of book, title of book, volume, edition (other than first), city, publisher, year. Luce BR, Manning WG, Siegel JE, et al. Estimating costs in cost-effectiveness analysis. In: Gold MR, Siegel JE, Russell LB, et al., eds., Cost-effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
Data, Models, and Methodology All authors must agree to make their data available at the Editor's request for examination and re-analysis by referees or other persons designated by the Editor. All models and methodologies must be presented in sufficient detail to be fully comprehensible to readers.
Author Anonymity From September 15, 2003, it is the policy of Value in Health that peer review of submitted manuscripts is double blinded, i.e., the reviewers do not know the names of the authors of manuscripts and the authors do not know the names of the reviewers. Blinded reviews are common practice at many important scientific and medical journals. The Value in Health editorial office will remove all authors names before the paper is sent out for peer review.
The Review Process All manuscripts deemed appropriate for Value in Health after initial screening will be reviewed by at least two peer reviewers. The objective of the journal is to complete peer review and reach editorial decision within ten to twelve weeks of submission, at which time the corresponding author will receive written notification, including anonymous reviewer commentary.
NEW: Online production tracking is now available for your article through Blackwell's Author Services. Author Services enables authors to track their article - once it has been accepted - through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit www.blackwellpublishing.com/bauthor for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.
Editorial Board
Editor-in-Chief Josephine Mauskopf, PhD RTI Health Solutions RTI International Research Triangle Park, NC jmauskopf@rti.org
Editorial Office ISPOR 3100 Princeton Pike, Suite 3E Lawrenceville, NJ 08648 viheditor@ispor.org
Managing Editor Stephen Priori spriori@ispor.org
Co-Editors Richard J. Milne, PhD rj.milne@auckland.ac.nz
John Hornberger, MD, MS jhornberger@sphereinstute.org
C. Daniel Mullins, PhD dmullins@rx.umaryland.edu
Michelle Naughton, PhD naughton@wfubmc.edu
Sean Sullivan, PhD sdsull@u.washington.edu
Johan L. Severens, PhD h.severens@beoz.unimaas.nl
Andrew Briggs, BA, MSc, DPhil a.briggs@clinmed.gla.ac.uk
William R. Lenderking, PhD william_r_lenderking@pfizer.com
Gordon G. Liu, PhD ggliu@unc.edu
Adrian Levy, PhD alevy@interchange.ubc.ca
Martin Backhouse, Dr PH martin.backhouse@novartis.com
Chris Bingefors, PhD, MSc chris.bingefors@farmaci.uu.se
Editorial Office Danielle Mroz dmroz@ispor.org
Management Advisory Board
Joyce Cramer Yale University School of Medicine New Haven, CT joyce.cramer@yale.edu
Scott Ramsey, PhD, MD Fred Hutchinson Cancer Research Center Seattle, WA sramsey@fhcrc.org
Adrian Towse, MPhil Office of Health Economics London, UK atowse@ohe.org
Editorial Advisory Board Marc L. Berger, MD Merck & Company, Inc. West Point, PA marc_berger@merck.com
J. Lyle Bootman, PhD University of Arizona Tucson, AZ bootman@pharmacy.arizona.edu
John Cairns, MD University of Aberdeen Aberdeen, Scotland, UK jcairns@abdn.ac.uk
Jonathan Cooke, MD, FRCP South Manchester University Hospitals Manchester, UK jonathan.cooke@man.ac.uk
Pete Fullerton, PhD University of Washington Seattle, WA peteful@msn.com
Jean Paul Gagnon, PhD Aventis Pharmaceuticals Inc. Parsippany, NJ jean.gagnon@sanofi-aventis.com
Henry Glick University of Pennsylvania Philadelphia, PA hlthsvrs@mail.med.upenn.edu
Timothy R. Hylan, PhD Pfizer New York, NY timothy.hylan@pfizer.com
Nelda Johnson, PharmD Outcomes Research & Design Inc. Lincoln Springs, OR neldajohnson@mindspring.com
Paul Kind, MPhil Centre for Health Economics University of York York, UK pk1@york.ac.uk
Paul C. Langley, PhD University of Minnesota Woodbury, MN P8366@MSN.com
Pablo Lapuerta, MD Bristol-Myers Squibb Princeton, NJ lapuertp@bms.com
Karl W. Lauterbach, MD, ScD University of Cologne Cologne, Germany lauterigmg@t-online.de
Steven E. Marx, PharmD, MS Abbott Laboratories Abbott Park, IL steve.marx@abbott.com
Karl A. Matuszewski, MS, PharmD Univ Health System Consortium Oak Brook, IL matuszewski@uhc.edu
William F. McGhan, PharmD, PhD University of the Sciences in Philadelphia Philadelphia, PA w.mcghan@usip.edu
Louis A. Morris, PhD Louis A. Morris & Assoc. Dix Hills, NY lmorris@optonline.net
Alan Mutnick, PharmD University of Virginia Health System Charlottesville, VA ahm3p@hscmail.mcc.virginia.edu
Peter J. Neumann, SciD Tufts--New England Medical School Boston, MA pneumann@tufts-nemc-org
Mark Nuijten, PhD, MD, MBA MEDTAP Jisp, The Netherlands marknuiten@planet.nl
Fredrick K. Orkin, MD, MBA Penn State University Hershey, PA frederickorkin@yahoo.com
Nicolaas Otten, PharmD Ottawa, Ontario, Canada nicolaaso@home.com
A. David Paltiel, PhD Yale University New Haven, CT david.paltiel@yale.edu
Chris L. Pashos, PhD Abt-associates HERQuLES Cambridge, MA chris_pashos@abtassoc.com
Dennis Revicki, PhD MEDTAP International Bethesda, MD dennis.Revicki@unitedbiosource.com
Kevin A. Schulman, MD Duke University Durham, NC schul012@mc.duke.edu
Jonathan Seltzer, MD, MBA Applied Clinical Intellegence, LLC Bala Cynwyd, PA jseltzer@a-ci.com
Hugh H. Tilson, MD, DrPH University of North Carolina at Chapel Hill Chapel Hill, NC hugh_tilson@unc.edu
George W. Torrance, PhD Innovus Research Inc. Burlington, Ontario, Canada gtorrance@innovus.com
Scott Weingarten, MD, MPH Zynx Health Los Angeles, CA weingarten@zynx.com
Milton C. Weinstein, PhD Harvard School of Public Health Boston, MA mcw@hsph.harvard.edu
|